• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
United Arab Emirates Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017 - Product Image

United Arab Emirates Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017

  • Published: December 2011
  • Region: United Arab Emirates
  • 71 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer HealthCare AG
  • Eli Lilly and Company
  • LifeScan, Inc.
  • NIPRO CORPORATION
  • Sanofi
  • MORE

United Arab Emirates Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017

Summary

”United Arab Emirates Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the United Arab Emirates Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Diabetes Care Devices In United Arab Emirates
3.1 Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Actual, 2003-2017
3.2 Diabetes Care Devices, United Arab Emirates, Category Volume (Units), 2003-2017
3.3 Diabetes Care Devices, United Arab Emirates, Company share (2009-2010)
4 Glucose Monitoring In United Arab Emirates
4.1 Glucose Monitoring Overall Revenue (2003-2017)
4.1.1 Blood Glucose Meters Revenue (2003-2017)
4.2 Glucose Monitoring Overall Volume (2003-2017)
4.2.1 Blood Glucose Meters Volume (2003-2017)
4.3 Glucose Monitoring Average Price (2003-2017)
4.4 Glucose Monitoring Distribution Share (2009-2010)
4.5 Glucose Monitoring, United Arab Emirates, Company share (2009-2010)
5 Insulin Delivery In United Arab Emirates
5.1 Insulin Delivery Overall Revenue (2003-2017)
5.1.1 Insulin Pens Revenue (2003-2017)
5.1.2 Insulin Pumps Revenue (2003-2017)
5.2 Insulin Delivery Overall Volume (2003-2017)
5.2.1 Insulin Pens Volume (2003-2017)
5.2.2 Insulin Pumps Volume (2003-2017)
5.3 Insulin Delivery Average Price (2003-2017)
5.4 Insulin Delivery Distribution Share (2009-2010)
5.5 Insulin Delivery, United Arab Emirates, Company share (2009-2010)
6 Overview of Key Companies in United Arab Emirates Diabetes Care Devices Market
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.2 Abbott Laboratories
6.2.1 Company Overview
6.3 Bayer HealthCare AG
6.3.1 Company Overview
6.4 LifeScan, Inc.
6.4.1 Company Overview
6.5 Novo Nordisk A/S
6.5.1 Company Overview
6.6 Becton, Dickinson and Company
6.6.1 Company Overview
6.7 Eli Lilly and Company
6.7.1 Company Overview
6.8 Sanofi
6.8.1 Company Overview
6.9 ARKRAY, Inc.
6.9.1 Company Overview
6.10 NIPRO CORPORATION
6.10.1 Company Overview
6.11 Smiths Medical
6.11.1 Company Overview
6.12 BIONIME Corporation
6.12.1 Company Overview
6.13 Terumo Corporation
6.13.1 Company Overview
6.14 Medtronic, Inc.
6.14.1 Company Overview
7 APPENDIX
7.1 Global Markets Direct Research Methodology
7.2 Definitions of Markets Covered in the Report
7.2.1 Diabetes Care Devices
7.3 Secondary Research
7.4 Primary Research
7.5 Models
7.6 Forecasts
7.7 Expert Panel Validation
7.8 Currency Conversion
7.9 Contact Us
7.10 Disclaimer

1.1 List of Tables
Table 1: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Actual, 2003-2017
Table 2: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 3: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 4: Diabetes Care Devices, United Arab Emirates, Category Volume (Units), 2003-2017
Table 5: Diabetes Care Devices, United Arab Emirates, Category Volume (Units), Historic, 2003-2010
Table 6: Diabetes Care Devices, United Arab Emirates, Category Volume (Units), Forecast, 2010-2017
Table 7: Diabetes Care Devices, United Arab Emirates, Company share by Revenue ($m), USD Actual, 2009-2010
Table 8: Glucose Monitoring, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 9: Glucose Monitoring, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 10: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Revenue ($m), USD Actual, Historic, 2003-2010
Table 11: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Revenue ($m), USD Actual, Forecast, 2010-2017
Table 12: Glucose Monitoring, United Arab Emirates, Volume (Units) by Segment, Historic, 2003-2010
Table 13: Glucose Monitoring, United Arab Emirates, Volume (Units) by Segment, Forecast, 2010-2017
Table 14: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Volume (Units), Historic, 2003-2010
Table 15: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Volume (Units), Forecast, 2010-2017
Table 16: Glucose Monitoring, United Arab Emirates, Average Price ($), Historic, 2003-2010
Table 17: Glucose Monitoring, United Arab Emirates, Average Price ($), Forecast, 2010-2017
Table 18: Glucose Monitoring, United Arab Emirates, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 19: Glucose Monitoring, United Arab Emirates, Company share by Revenue ($m), USD Actual 2009-2010
Table 20: Insulin Delivery, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 21: Insulin Delivery, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 22: Insulin Pens, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 23: Insulin Pens, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 24: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Revenue ($m), USD Actual, Historic, 2003-2010
Table 25: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Revenue ($m), USD Actual, Forecast, 2010-2017
Table 26: Insulin Delivery, United Arab Emirates, Volume (Units) by Segment, Historic, 2003-2010
Table 27: Insulin Delivery, United Arab Emirates, Volume (Units) by Segment, Forecast, 2010-2017
Table 28: Insulin Pens, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 29: Insulin Pens, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 30: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Volume (Units), Historic, 2003-2010
Table 31: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Volume (Units), Forecast, 2010-2017
Table 32: Insulin Delivery, United Arab Emirates, Average Price ($), Historic, 2003-2010
Table 33: Insulin Delivery, United Arab Emirates, Average Price ($), Forecast, 2010-2017
Table 34: Insulin Delivery, United Arab Emirates, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 35: Insulin Delivery, United Arab Emirates, Company share by Revenue ($m), USD Actual 2009-2010
Table 36: USD to Local Currency, United Arab Emirates, Average Actual Rate 2003-2010

1.2 List of Figures
Figure 1: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Actual, 2003-2017
Figure 2: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 3: Diabetes Care Devices, United Arab Emirates, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 4: Diabetes Care Devices, United Arab Emirates, Category Volume (Units), 2003-2017
Figure 5: Diabetes Care Devices, United Arab Emirates, Category Volume (Units), Historic, 2003-2010
Figure 6: Diabetes Care Devices, United Arab Emirates, Category Volume (Units), Forecast, 2010-2017
Figure 7: Diabetes Care Devices, United Arab Emirates, Company share (%), 2010
Figure 8: Glucose Monitoring, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 9: Glucose Monitoring, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 10: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Revenue ($m), USD Actual, Historic, 2003-2010
Figure 11: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 12: Glucose Monitoring, United Arab Emirates, Volume (Units) by Segment, Historic, 2003-2010
Figure 13: Glucose Monitoring, United Arab Emirates, Volume (Units) by Segment, Forecast, 2010-2017
Figure 14: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Volume (Units), Historic, 2003-2010
Figure 15: Blood Glucose Meters (Traditional Glucose Meters), United Arab Emirates, Volume (Units), Forecast, 2010-2017
Figure 16: Glucose Monitoring, United Arab Emirates, Company share (%), 2010
Figure 17: Insulin Delivery, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 18: Insulin Delivery, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 19: Insulin Pens, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 20: Insulin Pens, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 21: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Revenue ($m), USD Actual, Historic, 2003-2010
Figure 22: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 23: Insulin Delivery, United Arab Emirates, Volume (Units) by Segment, Historic, 2003-2010
Figure 24: Insulin Delivery, United Arab Emirates, Volume (Units) by Segment, Forecast, 2010-2017
Figure 25: Insulin Pens, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 26: Insulin Pens, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 27: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Volume (Units), Historic, 2003-2010
Figure 28: Insulin Pumps (Traditional Insulin Pumps), United Arab Emirates, Volume (Units), Forecast, 2010-2017
Figure 29: Insulin Delivery, United Arab Emirates, Company share (%), 2010
Figure 30: Global Markets Direct Methodology

F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Bayer HealthCare AG
LifeScan, Inc.
Novo Nordisk A/S
Becton, Dickinson and Company
Eli Lilly and Company
Sanofi
ARKRAY, Inc.
NIPRO CORPORATION
Smiths Medical
BIONIME Corporation
Terumo Corporation
Medtronic, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos